9-127507155-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_022833.4(NIBAN2):​c.1931C>T​(p.Pro644Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000553 in 1,610,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000057 ( 0 hom. )

Consequence

NIBAN2
NM_022833.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0280
Variant links:
Genes affected
NIBAN2 (HGNC:25282): (niban apoptosis regulator 2) Enables transcription coactivator activity. Involved in several processes, including gonadotropin secretion; positive regulation of transcription regulatory region DNA binding activity; and regulation of cellular macromolecule biosynthetic process. Located in several cellular components, including adherens junction; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1364733).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NIBAN2NM_022833.4 linkc.1931C>T p.Pro644Leu missense_variant 14/14 ENST00000373312.4 NP_073744.2 Q96TA1-1
NIBAN2NM_001035534.3 linkc.1892C>T p.Pro631Leu missense_variant 14/14 NP_001030611.1 Q96TA1-2A0A024R872
NIBAN2XM_005252135.3 linkc.2150C>T p.Pro717Leu missense_variant 15/15 XP_005252192.3
NIBAN2XM_011518925.2 linkc.2021C>T p.Pro674Leu missense_variant 15/15 XP_011517227.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NIBAN2ENST00000373312.4 linkc.1931C>T p.Pro644Leu missense_variant 14/141 NM_022833.4 ENSP00000362409.3 Q96TA1-1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000414
AC:
10
AN:
241766
Hom.:
0
AF XY:
0.0000456
AC XY:
6
AN XY:
131640
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000831
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.0000569
AC:
83
AN:
1457842
Hom.:
0
Cov.:
31
AF XY:
0.0000565
AC XY:
41
AN XY:
725114
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000453
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000720
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152182
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.000102
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 05, 2024The c.1931C>T (p.P644L) alteration is located in exon 14 (coding exon 14) of the FAM129B gene. This alteration results from a C to T substitution at nucleotide position 1931, causing the proline (P) at amino acid position 644 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.047
.;T
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
.;M
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.034
Sift
Benign
0.034
D;D
Sift4G
Uncertain
0.017
D;D
Polyphen
0.95
P;P
Vest4
0.12
MutPred
0.20
.;Loss of glycosylation at P644 (P = 0.0045);
MVP
0.20
MPC
0.34
ClinPred
0.38
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.068
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762228282; hg19: chr9-130269434; API